Semaglutide is the active ingredient used for diabetes and weight loss medications, which include Ozempic, Wegovy, and Rybelsus. It works as a glucagon-like peptide-1 (GLP-1) receptor, which helps increase insulin secretion and decrease glucagon release, and it can also empty your stomach faster. These effects help patients control their blood sugar. It’s also been advertised as a medication that can help people lose weight.
While manufacturers like Novo Nordisk and Eli Lilly make semaglutide’s benefits well-known, they aren’t as open about the ingredient’s side effects.
A study published in the National Library of Medicine (NLM) found that semaglutide mostly causes problems in a patient’s gastrointestinal system. Their study found that 5.1% to 23.2% of patients experience nausea, 5.1% to 15% experience diarrhea, and 2.9% to 9.9% experience vomiting.
Though not as common as the issues above, semaglutide has also been found to cause more serious issues that also make you eligible to file a claim to recover financial compensation. These include:
If you or a relative has experienced any of the above after taking Ozempic, Wegovy, and Rybelsus contact us immediately.
If you didn’t experience any of the side effects or symptoms described above prior to taking Ozempic, Wegovy, or Rybelsus, then there’s a good chance that you got them from taking semaglutide. The process of getting your just compensation starts with a thorough assessment of your claim. But to help you understand your eligibility, consider these conditions:
You can also reach out to us to see if you are eligible to file a semaglutide claim if you experienced persistent vomiting (4 weeks or more) with hospitalization or ER visit while taking the drug or within 60 days of stopping and if you were hospitalized for any gastric issue while using semaglutide.
There have been several successful claims made against manufacturers of semaglutide without the right warnings for the side effects. The very first lawsuit was filed on August 2, 2023, against Ozempic over gastrointestinal injuries caused by the medication. Since then, there have been filed over 1440 cases in the Eastern District of Pennsylvania alone.
In July 2024, plaintiffs also took semaglutide manufacturers to court over vision loss caused by the medication. The success of these cases only proves that the manufacturers of semaglutide medications did fail when it comes to highlighting the side effects of their medication.
If you or any of your relatives are suffering from gastrointestinal problems or vision loss, we can help you file a claim. You can start by gathering all of your medical records and that you believe prove you’re suffering from the effects of semaglutide. From there, our team will take the helm and help you establish eligibility. If you have a case we will refer you to an attorney who specializes in these cases.
10 Minutes Over the Phone
*No fees unless compensation is obtained